BIG PHARMA WATCH: CEO UNDERCUTS OWN INDUSTRY’S DOOM AND GLOOM RHETORIC ON RECENT DRUG PRICING SOLUTIONS

Novartis Exec Calls Policy to Keep Price Hikes Below Inflation “Manageable” and Suggests Rx Solutions Will Have No Impact on Profits Big Pharma giant Novartis signaled plans at an investor event

09-22-2022 Read More

DOSE OF REALITY: BIG PHARMA’S PRICING PRACTICES DRIVE CRISIS OF AFFORDABILITY FOR CANCER PATIENTS

Shining a Light on How Big Pharma is Rapidly Increasing Prices on Oncology Drugs A new blog from America’s Health Insurance Plans (AHIP) highlights how Big Pharma’s pricing practices on oncology

09-20-2022 Read More

ICYMI: WHAT COMES NEXT AFTER MAJOR STEP FORWARD ON DRUG PRICING

What Comes Next After Major Step Forward on Drug Pricing Real Clear Health Lauren Aronson September 19, 2022 With the passage of the Inflation Reduction Act of 2022

09-19-2022 Read More

BIG PHARMA WATCH: REPORT FINDS BIG PHARMA’S “PERVASIVE” PATENT ABUSE “THE ROOT OF THE DRUG PRICING CRISIS”

I-MAK Analysis Finds Anti-Competitive Practices That Extend Exclusivity Will Cause U.S. Patients To Spend $167 Billion on Just Three Branded Drugs Over Seven Years A new report from the Initiative

09-15-2022 Read More

CSRXP: MODERNA MUST BE PUT ON NOTICE THAT PATIENTS, POLICYMAKERS WOULD FIND SIX-FOLD VACCINE PRICE HIKE UNCONSCIONABLE

Big Pharma Giant Eyes Massive Price Hike on COVID-19 Vaccine Developed with $1.3 Billion Investment from American Taxpayers For Immediate Release Contact: Jon Conradi 860-235-3884

09-12-2022 Read More

BIG PHARMA WATCH: STUDY FINDS BIG PHARMA PROFITS THROUGH ANTI-COMPETITIVE KICKBACK SCHEMES CLOAKED AS CHARITY

Researchers Say Brand Name Drug Companies’ So-Called Patient Assistance Programs Boost Sales of High-Priced Products and “Violate the Spirit of Medicare’s Anti-Kickback Statute” A new study

09-9-2022 Read More

SECOND OPINION: AVIK ROY DEBUNKS BIG PHARMA’S INNOVATION RHETORIC

FREOPP President Explains Pharmaceutical Industry Arguments Are “Factually Wrong” and Highlights the Need for Additional, Market-Based Solutions to Increase Competition In an interview on

09-1-2022 Read More

DOSE OF REALITY: REPORT FINDS RX SPENDING CONTINUED TO RISE AS BIG PHARMA MAINTAINED BUSINESS-AS-USUAL APPROACH TO PRICE-GOUGING

Analysis Highlights How Escalating Prescription Drug Costs, Driven By Big Pharma’s Egregious Practices, a Burden for Patients and the Health Care System A new report this week from the Health

09-1-2022 Read More

CSRXP APPLAUDS PRESIDENT BIDEN FOR TAKING MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE

Biden Administration and Congress Deliver Positive Progress on Longstanding Commitments to Lower Prescription Drug Prices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]

08-16-2022 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.